Sanofi
Anti-CEACAM5 antibodies and uses thereof
Last updated:
Abstract:
Antibodies are provided which bind human and Macaca fascicularis CEACAM5 proteins, as well as isolated nucleic acids, vectors and host cells comprising a sequence encoding the antibodies. Also provided are immunoconjugates comprising the antibodies conjugated or linked to a growth-inhibitory agent, and to pharmaceutical compositions comprising the antibodies, or immunoconjugates of the invention. The antibodies or immunoconjugates are used for the treatment of cancer or for diagnostic purposes.
Status:
Grant
Type:
Utility
Filling date:
1 Mar 2017
Issue date:
29 Oct 2019